May 13-17, 2025

28th Annual meeting of the American Society of Gene and Cell Therapy

Stephen J. Russell, M.D., Ph.D., Vyriad President and Chief Executive Officer will be presenting “In Vivo Cell Engineering Using Targeted Lentiviral Vectors” at the Lentivirus Workshop during the ASGCT 28th annual meeting in New Orleans.  Luke Russell, Ph.D., Vyriad Vice President of Business Development and Operations will be attending the ASGCT annual meeting in New Orleans.